Carl-Johan Gustafson
Vorstandsvorsitzender bei NATTARO LABS AB
Profil
Carl-Johan Gustafson is currently the Chief Executive Officer at Nattaro Labs AB and the Director at MVIC AB.
He is a graduate of the University of Lund and has an undergraduate degree from ESCP Europe Campus Paris.
Aktive Positionen von Carl-Johan Gustafson
| Unternehmen | Position | Beginn |
|---|---|---|
| NATTARO LABS AB | Vorstandsvorsitzender | 01.01.2015 |
MVIC AB
 MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Direktor/Vorstandsmitglied | 01.01.2019 |
Ausbildung von Carl-Johan Gustafson
| University of Lund | Graduate Degree |
| ESCP Europe Campus Paris | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NATTARO LABS AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MVIC AB
MVIC AB Miscellaneous Commercial ServicesCommercial Services MVIC AB is an inhalation CRO and partner with over 70 project managers and specialists in discovery, formulation, regulatory, device, and product development. MVIC is based in Stockholm, SE, and has GMP facilities, well-equipped labs, advanced instrumentation, and highly skilled staff. The Swedish company has extensive experience in inhalation product testing and characterization, with standardized procedures or customized to customer requirements. The private company is a team of 70 inhalation experts, 27 with a PhD, covering areas from discovery up to late-phase development. | Commercial Services |
